Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation.

Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL.

MBio. 2017 Dec 5;8(6). pii: e01991-17. doi: 10.1128/mBio.01991-17.

2.

Examination of the pathogenic potential of Candida albicans filamentous cells in an animal model of haematogenously disseminated candidiasis.

Cleary IA, Reinhard SM, Lazzell AL, Monteagudo C, Thomas DP, Lopez-Ribot JL, Saville SP.

FEMS Yeast Res. 2016 Mar;16(2):fow011. doi: 10.1093/femsyr/fow011. Epub 2016 Feb 5.

3.

A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance.

Pierce CG, Chaturvedi AK, Lazzell AL, Powell AT, Saville SP, McHardy SF, Lopez-Ribot JL.

NPJ Biofilms Microbiomes. 2015;1. pii: 15012. Epub 2015 Aug 12.

4.

Ppg1, a PP2A-type protein phosphatase, controls filament extension and virulence in Candida albicans.

Albataineh MT, Lazzell A, Lopez-Ribot JL, Kadosh D.

Eukaryot Cell. 2014 Dec;13(12):1538-47. doi: 10.1128/EC.00199-14. Epub 2014 Oct 17.

5.

BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence.

Cleary IA, Lazzell AL, Monteagudo C, Thomas DP, Saville SP.

Mol Microbiol. 2012 Aug;85(3):557-73. doi: 10.1111/j.1365-2958.2012.08127.x. Epub 2012 Jul 5.

6.

Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis.

Martins M, Lazzell AL, Lopez-Ribot JL, Henriques M, Oliveira R.

J Basic Microbiol. 2012 Aug;52(4):487-91. doi: 10.1002/jobm.201100158. Epub 2011 Nov 3.

PMID:
22052380
7.

Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease.

Chaturvedi AK, Lazzell AL, Saville SP, Wormley FL Jr, Monteagudo C, Lopez-Ribot JL.

PLoS One. 2011;6(5):e20449. doi: 10.1371/journal.pone.0020449. Epub 2011 May 25.

8.

Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis.

Cleary IA, Reinhard SM, Miller CL, Murdoch C, Thornhill MH, Lazzell AL, Monteagudo C, Thomas DP, Saville SP.

Microbiology. 2011 Jun;157(Pt 6):1806-15. doi: 10.1099/mic.0.046326-0. Epub 2011 Mar 24.

9.

Pseudohyphal regulation by the transcription factor Rfg1p in Candida albicans.

Cleary IA, Mulabagal P, Reinhard SM, Yadev NP, Murdoch C, Thornhill MH, Lazzell AL, Monteagudo C, Thomas DP, Saville SP.

Eukaryot Cell. 2010 Sep;9(9):1363-73. doi: 10.1128/EC.00088-10. Epub 2010 Jul 23.

10.

Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.

Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL.

J Antimicrob Chemother. 2009 Sep;64(3):567-70. doi: 10.1093/jac/dkp242. Epub 2009 Jul 7.

PMID:
19584104
11.

Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.

Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL.

Clin Vaccine Immunol. 2009 Mar;16(3):430-2. doi: 10.1128/CVI.00480-08. Epub 2009 Jan 14.

12.

Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence.

Carlisle PL, Banerjee M, Lazzell A, Monteagudo C, López-Ribot JL, Kadosh D.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):599-604. doi: 10.1073/pnas.0804061106. Epub 2008 Dec 30.

13.

Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence.

Lee SA, Jones J, Hardison S, Kot J, Khalique Z, Bernardo SM, Lazzell A, Monteagudo C, Lopez-Ribot J.

Mycopathologia. 2009 Feb;167(2):55-63. doi: 10.1007/s11046-008-9155-7. Epub 2008 Sep 24.

14.

Localization of betav tubulin in the cochlea and cultured cells with a novel monoclonal antibody.

Banerjee A, Jensen-Smith H, Lazzell A, Prasad V, Elguezabal G, Hallworth R, Ludueña RF.

Cell Motil Cytoskeleton. 2008 Jun;65(6):505-14. doi: 10.1002/cm.20280.

PMID:
18412253
15.

UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence.

Banerjee M, Thompson DS, Lazzell A, Carlisle PL, Pierce C, Monteagudo C, López-Ribot JL, Kadosh D.

Mol Biol Cell. 2008 Apr;19(4):1354-65. doi: 10.1091/mbc.E07-11-1110. Epub 2008 Jan 23.

16.
17.

A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis.

Thomas DP, Viudes A, Monteagudo C, Lazzell AL, Saville SP, López-Ribot JL.

Proteomics. 2006 Nov;6(22):6033-41.

PMID:
17051645
18.

Inhibition of filamentation can be used to treat disseminated candidiasis.

Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, Monteagudo C, Lopez-Ribot JL, Milne GT.

Antimicrob Agents Chemother. 2006 Oct;50(10):3312-6.

19.

Inducible defense mechanism against nitric oxide in Candida albicans.

Ullmann BD, Myers H, Chiranand W, Lazzell AL, Zhao Q, Vega LA, Lopez-Ribot JL, Gardner PR, Gustin MC.

Eukaryot Cell. 2004 Jun;3(3):715-23.

21.

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis.

Viudes A, Lazzell A, Perea S, Kirkpatrick WR, Peman J, Patterson TF, Martinez JP, López-Ribot JL.

FEMS Microbiol Lett. 2004 Mar 19;232(2):133-8.

22.
23.

Biofunctional domains of the Mycoplasma pneumoniae P30 adhesin.

Dallo SF, Lazzell AL, Chavoya A, Reddy SP, Baseman JB.

Infect Immun. 1996 Jul;64(7):2595-601.

24.

Mycoplasma pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate.

Tully JG, Rose DL, Baseman JB, Dallo SF, Lazzell AL, Davis CP.

J Clin Microbiol. 1995 Jul;33(7):1851-5.

25.

Supplemental Content

Loading ...
Support Center